Status:
NOT_YET_RECRUITING
Robotic Right Hemicolectomy Versus Laparoscopic Right Hemicolectomy
Lead Sponsor:
Jeremy Meyer
Collaborating Sponsors:
University Hospital, Geneva
Spital Biel, Switzerland
Conditions:
Colorectal Neoplasms
Colorectal Neoplasms Malignant
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Robotic right hemicolectomy with intra-corporeal anastomosis may have better short-term recovery outcomes and decreased incidence of incisional hernia when compared to the laparoscopic actual standard...
Detailed Description
During laparoscopic right hemicolectomy (lapRHC) for cancer or polyp, intra-corporeal anastomosis (ICA) offers better short-term recovery and decreased incidence of incisional hernia (IH) when compare...
Eligibility Criteria
Inclusion
- Adult patients requiring elective minimally invasive RHC for cT1-T3 Nx M0 cancer of the right colon (including cancer of the appendix, caecum, ascending colon and hepatic flexure).
Exclusion
- Not scheduled for minimally invasive RHC (refuses surgery and/or planned open approach)
- Emergency surgery
- Hereditary colorectal cancer
- Inflammatory bowel disease
- Synchronous resection of (an)other organ(s)
- Synchronous surgical procedure (including more extended resection of the lower gastrointestinal tract)
- cT4
- cM+
- History of laparotomy
- Pregnancy
- No anastomosis planned
- Unable to provide informed consent
- No informed consent
Key Trial Info
Start Date :
August 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2026
Estimated Enrollment :
70 Patients enrolled
Trial Details
Trial ID
NCT06067620
Start Date
August 1 2024
End Date
December 31 2026
Last Update
May 10 2024
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.